2017, BioTech and Health Policy - Connected Health Pulse

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2017

BioTech

Health Policy

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Health Populi

JULY 1, 2019

To address that challenge, in 2017 PLM secured a $100 million (controlling interest) investment from iCarbonX , a Chinese company that is amassing patient data to discover cures for disease. When this occurred, it didn’t cause more than a ripple of interest outside biotech. But the U.S. citizens’ personal data.

Pharmaceuticals

Pharmaceuticals HIPAA BioTech Patient Experience

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

Health Populi

MAY 8, 2019

Two-thirds of Rx’s were dispensed to treat chronic conditions, notably hypertension, mental health, lipid management, diabetes, and anti-coagulants. In 2017, nearly 60% of new therapy starts were for the Flucelvax Quadrivalent flu vaccine. increase over 2017 net of rebates, discounts, and price concessions.

Medicare

Medicare BioTech Pharmaceuticals Mental health

Webinars

Less Stress, More Success: Accounting Best Practices & Processes for 2025

MORE WEBINARS

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

Webinars

Stay Connected